Viewpoint
Combination-Only Approvals as a Barrier to Affordable HIV Care
JAMA 10.1001/jama.2025.21935December 01, 2025 at 11:00 AM EST
This Viewpoint discusses the barrier that combination-only antiretroviral therapy drugs have been to access of affordable HIV care.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.